Structure of the extracellular region of HER3 reveals an interdomain tether
- PMID: 12154198
- DOI: 10.1126/science.1074611
Structure of the extracellular region of HER3 reveals an interdomain tether
Abstract
We have determined the 2.6 angstrom crystal structure of the entire extracellular region of human HER3 (ErbB3), a member of the epidermal growth factor receptor (EGFR) family. The structure consists of four domains with structural homology to domains found in the type I insulin-like growth factor receptor. The HER3 structure reveals a contact between domains II and IV that constrains the relative orientations of ligand-binding domains and provides a structural basis for understanding both multiple-affinity forms of EGFRs and conformational changes induced in the receptor by ligand binding during signaling. These results also suggest new therapeutic approaches to modulating the behavior of members of the EGFR family.
Similar articles
-
The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation.Biochemistry. 2005 Dec 6;44(48):15842-57. doi: 10.1021/bi0515220. Biochemistry. 2005. PMID: 16313187
-
Bivalence of EGF-like ligands drives the ErbB signaling network.EMBO J. 1997 Aug 15;16(16):4938-50. doi: 10.1093/emboj/16.16.4938. EMBO J. 1997. PMID: 9305636 Free PMC article.
-
Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.J Mol Biol. 2008 Jan 18;375(3):650-60. doi: 10.1016/j.jmb.2007.10.085. Epub 2007 Nov 7. J Mol Biol. 2008. PMID: 18045614
-
Epidermal growth factor receptor (EGFR) signaling in cancer.Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
-
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.Growth Factors. 2006 Jun;24(2):121-36. doi: 10.1080/08977190600634373. Growth Factors. 2006. PMID: 16801132 Review.
Cited by
-
Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.J Mol Model. 2013 Feb;19(2):931-41. doi: 10.1007/s00894-012-1613-y. Epub 2012 Oct 23. J Mol Model. 2013. PMID: 23090500
-
Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.J Biomol Struct Dyn. 2012;30(5):594-606. doi: 10.1080/07391102.2012.687525. Epub 2012 Jun 26. J Biomol Struct Dyn. 2012. PMID: 22731912 Free PMC article.
-
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth.Vaccines (Basel). 2024 Jul 21;12(7):808. doi: 10.3390/vaccines12070808. Vaccines (Basel). 2024. PMID: 39066446 Free PMC article.
-
Human epidermal growth factor receptor 2-targeted therapies in breast cancer.Expert Opin Biol Ther. 2013 Jul;13(7):949-52. doi: 10.1517/14712598.2013.789497. Epub 2013 Apr 9. Expert Opin Biol Ther. 2013. PMID: 23565676 Free PMC article.
-
The ERBB network: at last, cancer therapy meets systems biology.Nat Rev Cancer. 2012 Jul 12;12(8):553-63. doi: 10.1038/nrc3309. Nat Rev Cancer. 2012. PMID: 22785351 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous